An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV) …

E Frangou, D Vassilopoulos, J Boletis… - Autoimmunity reviews, 2019 - Elsevier
Neutrophils derive from hematopoietic stem cells (HSCs) with systemic inflammation driving
their activation and differentiation to myeloid progenitors to ensure enhanced myelopoiesis …

[HTML][HTML] The Th17/IL-17 axis and kidney diseases, with focus on lupus nephritis

FC Paquissi, H Abensur - Frontiers in Medicine, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE) is a disease characterized by dysregulation and
hyperreactivity of the immune response at various levels, including hyperactivation of …

[PDF][PDF] One year in review 2017: systemic lupus erythematosus

GMC La Paglia, MC Leone, G Lepri… - Clin Exp …, 2017 - clinexprheumatol.org
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominately
affects women. It is characterised by a broad spectrum of clinical manifestations, however, its …

[HTML][HTML] Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy

C Lavoz, YS Matus, M Orejudo, JD Carpio, A Droguett… - Kidney International, 2019 - Elsevier
Diabetic nephropathy (DN) is one of the most common complications of diabetes, and
currently the first end-stage renal disease worldwide. New strategies to treat DN using …

IL-12 and IL-23/Th17 axis in systemic lupus erythematosus

M Larosa, M Zen, M Gatto, D Jesus… - Experimental …, 2019 - journals.sagepub.com
Systemic lupus erythematosus (SLE) is a very complex disease where multiple
immunological pathways can concur in inducing tissue damage. Cytokines are key …

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway

S Oon, NJ Wilson, I Wicks - Clinical & translational immunology, 2016 - Wiley Online Library
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by
impaired immune tolerance, resulting in the generation of pathogenic autoantibodies and …

Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis

S Qi, Q Chen, D Xu, N Xie, Y Dai - Lupus, 2018 - journals.sagepub.com
Systemic lupus erythematosus (SLE) is a type of autoimmune disease that damages multiple
organs, including the heart, joints, liver and kidneys. The main characteristics of SLE are the …

Update on the cellular and molecular aspects of lupus nephritis

E Frangou, S Georgakis, G Bertsias - Clinical Immunology, 2020 - Elsevier
Recent progress has highlighted the involvement of a variety of innate and adaptive immune
cells in lupus nephritis. These include activated neutrophils producing extracellular …

Kidney-Specific Interleukin-17 Responses During Infection and Injury

D Peroumal, PS Biswas - Annual Review of Immunology, 2023 - annualreviews.org
The kidneys are life-sustaining organs that are vital to removing waste from our body.
Because of their anatomic position and high blood flow, the kidneys are vulnerable to …

[HTML][HTML] NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus

D Yang, Z Tian, M Zhang, W Yang, J Tang, Y Wu… - Scientific reports, 2017 - nature.com
Systemic lupus erythematosus (SLE) features a decreased pool of CD4+ CD25+ Foxp3+ T
regulatory (Treg) cells. We had previously observed NKG2D+ CD4+ T cell expansion in …